ABCL AbCellera Biologics Inc.

NASDAQ
$11.03

AbCellera Biologics Inc. (ABCL) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 2 buyers in the last 30 days 3 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
3
3 transactions
Insiders selling
0
0 transactions
Purchases
$1.4M
122,778 shares
Sales
$0
0 shares
Net activity
$1.4M
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 13, 2026 , by Booth Andrew .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Booth Andrew Chief Financial Officer Buy 8,600 $11.33 $97.4K 491,400
Thermopylae Holdings Ltd. 10% Owner Buy 60,565 $11.54 $698.9K 56,194,662
Hayden Michael R Director Buy 53,613 $10.64 $570.4K 1,373,397

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.